GRCL
$14.37
Gracell Biotechnologies Inc ADR
$.06
.42%
GRCL
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.05)
Revenue:  N/A
Monday
Aug 16
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when GRCL reports earnings?
Beat
Meet
Miss

Where is GRCL's stock price going from here?
Up
Flat
Down
Stock chart of GRCL
Analysts
Summary of analysts' recommendations for GRCL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company. It involved in discovering and developing breakthrough cell therapies to address unmet medical needs in the treatment of cancer. Gracell Biotechnologies Inc. is based in SUZHOU, China.